rss
Br J Ophthalmol 92:120-125 doi:10.1136/bjo.2007.125179
  • Original Article
    • Laboratory science

Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation

Table 2 PGE2 levels in aqueous humour
Placebo (pg/mL) Meloxicam 0.03% (pg/mL) Diclofenac 0.1% (pg/mL)
Basal (SD) 21 (14) 21 (14) 21 (14)
Croton oil ⩾1000 ⩾1000 ⩾1000
4 h (SD) ⩾1000 ⩾1000 32 (11)*
24 h (SD) ⩾1000 120 (39)* 12 (3)*
72 h (SD) ⩾1000 35 (4)* ⩾1000
144 h (SD) 33 (11) 27 (6) ⩾1000*

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.